revised supplementary File.docx (6.65 MB)

nnm-2021-0329 - Supplementary Materials

dataset

posted on 2021-11-01, 09:29 authored by Hui Gao, Xiangbo Gou, Chaoqi Li

Supplementary Materials

Funding

This work was supported by the National Natural Science Foundation of China (U20A20260, 22075209).

History

Usage metrics

Read the peer-reviewed publication

A doxorubicin nanomedicine based on ginsenoside Rg1 with alleviated cardiotoxicity and enhanced anti-tumor activity

Categories

Keywords

nanomedicine delivery tumor targeting therapy cardiac protective effect doxorubicin apoptosis ginsenoside Rg1 cardiovascular cardiotoxicity breast cancer nanoparticles Chemotherapy Toxicology (incl. Clinical Toxicology)

Licence

CC BY-NC-ND 4.0

Exports